EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cold Atmospheric Plasma Versus Cisplatin Against Oral Squamous Cell Carcinoma: A Mitochondrial Targeting Study

Mona Afrasiabi, Ghazaleh Tahmasebi, Esmaeil Eslami, Enayatollah Seydi, Jalal Pourahmad

Iranian Journal of Pharmaceutical Research · 2022

DOI: 10.5812/ijpr-124106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iranian Journal of Pharmaceutical Research, 2022. Verfasst von Mona Afrasiabi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: Plasma therapy and the study of the effects of cold atmospheric plasma (CAP) on tissues and living cells have been considered by scientific researchers in recent years. CAP is used in the treatment of cancer, but its anti-cancer mechanism has not been fully studied. Therefore, we studied the toxicity effect of CAP by using argon as feed gas and the synergistic effects of CAP with cisplatin on tumor cells and mitochondria isolated from tumor legions of the rat model of oral squamous cell carcinoma (OSCC). For this reason, we determined the possible toxic alterations of CAP on mitochondrial upstream events and activation of caspase-3 as the key major downstream event of apoptosis. Also, the effects of cisplatin (10 µM) as a positive control and its synergistic effects with CAP (IC50 concentration) were investigated. The results showed that CAP reduced mitochondrial dysfunction by reduction in succinate dehydrogenase (SDH) activity. Also, CAP in concentrations of 1200, 2400, and 4800 a.u. has been able to increase the level of reactive oxygen species (ROS), mitochondrial swelling, damage to the mitochondrial membrane, cytochrome c release, and activation of the final mediator of apoptosis (caspase-3) only in the OSCC group. CAP at 4800 a.u concentration had similar effects to cisplatin (10 µM). Synergistic effects between CAP (2400 a.u) and cisplatin (10 µM) have also been reported. Based on all results CAP showed positive and promising results on mitochondrial upstream parameters leading to activation of caspase-3, the final mediator of apoptosis only on OSCC cells and mitochondria without any significant effect on normal cells and mitochondria.

Schlagwörter

Stichwörter der Autor:innen

ApoptosisCold PlasmaMitochondriaReactive Oxygen SpeciesSquamous Cell Carcinoma of Head and Neck

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Atomic/Molecular Physics, Faculty of Physics, Iran University of Science and Technology, Tehran, Iran.
  • Department of Occupational Health and Safety Engineering, School of Health, Alborz University of Medical Sciences, Karaj, Iran.
  • Research Center for Health, Safety and Environment, Alborz University of Medical Sciences, Karaj, Iran.

Zitieren

APA

Afrasiabi, M., Tahmasebi, G., Eslami, E., Seydi, E., & Pourahmad, J. (2022). Cold Atmospheric Plasma Versus Cisplatin Against Oral Squamous Cell Carcinoma: A Mitochondrial Targeting Study. Iranian Journal of Pharmaceutical Research. https://doi.org/10.5812/ijpr-124106

Vancouver

Afrasiabi M, Tahmasebi G, Eslami E, Seydi E, Pourahmad J. Cold Atmospheric Plasma Versus Cisplatin Against Oral Squamous Cell Carcinoma: A Mitochondrial Targeting Study. Iranian Journal of Pharmaceutical Research. 2022. doi:10.5812/ijpr-124106

BibTeX
@article{Afrasiabi2022,
  author = {Afrasiabi, Mona and Tahmasebi, Ghazaleh and Eslami, Esmaeil and Seydi, Enayatollah and Pourahmad, Jalal},
  title = {Cold Atmospheric Plasma Versus Cisplatin Against Oral Squamous Cell Carcinoma: A Mitochondrial Targeting Study},
  journal = {Iranian Journal of Pharmaceutical Research},
  year = {2022},
  doi = {10.5812/ijpr-124106}
}
Kostenlos starten →